# Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults

> **NCT01071889** · PHASE1,PHASE2 · COMPLETED · sponsor: **Coeruleus Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Flumazenil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01071889
- **Lead sponsor:** Coeruleus Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-08
- **Final completion:** 2013-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2015-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01071889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01071889, "Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01071889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*